Literature DB >> 20546030

Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.

C Barnes, A Davis, J Furmedge, B Egan, L Donnan, P Monagle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20546030     DOI： 10.1111/j.1365-2516.2007.01446.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

1.  Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient.

Authors:  Priya Verghese; Stephen Darrow; Margaret H Kurth; Robyn C Reed; Youngki Kim; Susan Kearney
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

2.  Clinical Care of Bone Health in Patients on the Immune Tolerance Induction's Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia.

Authors:  Zahra Rezaieyazdi; Hassan Mansouritorghabeh
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

3.  Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B.

Authors:  Federico Mingozzi; Yifeng Chen; Samuel L Murphy; Shyrie C Edmonson; Alex Tai; Sandra D Price; Mark E Metzger; Shangzhen Zhou; J Fraser Wright; Robert E Donahue; Cynthia E Dunbar; Katherine A High
Journal:  Mol Ther       Date:  2012-05-08       Impact factor: 11.454
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.